Status:
SUSPENDED
Terahertz Metamaterials for Tumour Marker Concentration Identification
Lead Sponsor:
Durham University
Collaborating Sponsors:
County Durham and Darlington NHS Foundation Trust
Conditions:
Malignant Tumour
Eligibility:
All Genders
18-100 years
Brief Summary
The research the investigators plan to undertake involves the use of a metamaterial at terahertz frequencies. Serum samples will be tested using the metamaterial to determine if this method can be use...
Detailed Description
The research the investigators plan to undertake involves the use of a paper substrate with a gold metamaterial on top or a plastic substrate with gold metamaterial on top in physical contact with pap...
Eligibility Criteria
Inclusion
- Any patient recommended by their health professional to be tested for any of the tumour markers being studied at County Durham and Darlington NHS Foundation Trust for any reason.
Exclusion
- Patients with known bloodborne pathogens.
Key Trial Info
Start Date :
May 17 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2025
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04125524
Start Date
May 17 2021
End Date
October 1 2025
Last Update
November 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Engineering Durham University
Durham, United Kingdom, DH1 3LE